| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC3204 |
| Trial ID | NCT05576181 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ThisCAR-T19 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia |
| Year | 2022 |
| Country | Germany |
| Company sponsor | Fundamenta Therapeutics, Ltd. |
| Other ID(s) | ThisCART19 FT400-007 |
| Cohort 1 | |||||||||||
|
|||||||||||